BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16401355)

  • 1. RNA repair for haemophilia A.
    Chao H; Walsh CE
    Expert Rev Mol Med; 2006 Jan; 8(1):1-8. PubMed ID: 16401355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
    Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
    Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spliceosome-mediated RNA trans-splicing.
    Yang Y; Walsh CE
    Mol Ther; 2005 Dec; 12(6):1006-12. PubMed ID: 16226059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
    Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
    Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA repair using spliceosome-mediated RNA trans-splicing.
    Mansfield SG; Chao H; Walsh CE
    Trends Mol Med; 2004 Jun; 10(6):263-8. PubMed ID: 15177190
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy progress and prospects: reprograming gene expression by trans-splicing.
    Mitchell LG; McGarrity GJ
    Gene Ther; 2005 Oct; 12(20):1477-85. PubMed ID: 16121205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosome-mediated RNA trans-splicing.
    Walls ZF; Puttaraju M; Temple GF; Gambhir SS
    J Nucl Med; 2008 Jul; 49(7):1146-54. PubMed ID: 18552150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy.
    Puttaraju M; Jamison SF; Mansfield SG; Garcia-Blanco MA; Mitchell LG
    Nat Biotechnol; 1999 Mar; 17(3):246-52. PubMed ID: 10096291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA reprogramming and repair based on trans-splicing group I ribozymes.
    Fiskaa T; Birgisdottir AB
    N Biotechnol; 2010 Jul; 27(3):194-203. PubMed ID: 20219714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing.
    Puttaraju M; DiPasquale J; Baker CC; Mitchell LG; Garcia-Blanco MA
    Mol Ther; 2001 Aug; 4(2):105-14. PubMed ID: 11482981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reprogramming RNA via trans-splicing].
    Ohuchi S
    Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2484-8. PubMed ID: 17471967
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia gene therapy: novel rAAV vectors and RNA repair strategy.
    Chao H; Walsh CE
    Curr Opin Mol Ther; 2002 Oct; 4(5):499-504. PubMed ID: 12435052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging regulation of endogenous gene expression using spliceosome-mediated trans-splicing.
    Ponomarev V
    J Nucl Med; 2008 Jul; 49(7):1035-7. PubMed ID: 18552134
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing.
    Pergolizzi RG; Crystal RG
    C R Biol; 2004 Aug; 327(8):695-709. PubMed ID: 15506518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
    Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
    Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing.
    Chen HY; Kathirvel P; Yee WC; Lai PS
    Gene Ther; 2009 Feb; 16(2):211-7. PubMed ID: 18923454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and genetic therapies for haemophilia.
    Lillicrap D; VandenDriessche T; High K
    Haemophilia; 2006 Jul; 12 Suppl 3():36-41. PubMed ID: 16683995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing segregation: the minor spliceosome acts outside the nucleus and controls cell proliferation.
    König H; Matter N; Bader R; Thiele W; Müller F
    Cell; 2007 Nov; 131(4):718-29. PubMed ID: 18022366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMaRT for Therapeutic Purposes.
    Riedmayr LM
    Methods Mol Biol; 2020; 2079():219-232. PubMed ID: 31728974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.